Itano, Japan

Mitugi Yasumoto


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Itano, JA (1978)
  • Tokushima, JA (1978)

Company Filing History:


Years Active: 1978

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mitugi Yasumoto: Innovator in Pharmaceutical Chemistry

Introduction

Mitugi Yasumoto is a notable inventor based in Itano, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical applications. With a total of 2 patents, Yasumoto's work focuses on the synthesis and application of 5-fluoropyrimidin-4-one derivatives.

Latest Patents

Yasumoto's latest patents include the preparation of 5-fluoropyrimidin-4-one derivatives and compositions. The first patent describes a 5-fluoropyrimidin-4-one derivative represented by a specific formula, where R can be a straight-chain or branched-chain alkyl with 4 to 18 carbon atoms, or other specified groups. The second patent outlines a similar derivative and includes processes for preparing the compound, as well as an anti-tumor composition that utilizes the derivative as an effective component along with an excipient.

Career Highlights

Yasumoto is currently employed at Taisho Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has been instrumental in creating new therapeutic options for patients, particularly in oncology.

Collaborations

Throughout his career, Yasumoto has collaborated with esteemed colleagues such as Junichi Yamashita and Ichiro Yamawaki. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Mitugi Yasumoto's contributions to pharmaceutical chemistry exemplify the impact of innovative research on medical science. His patents and ongoing work at Taisho Pharmaceutical Co., Ltd. highlight his commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…